Raay Neo Pharma launches operations with portfolio of 90 formulations across therapy segments
Company outlines expansion across multiple states and pipeline of formulations under development
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Kashiv BioSciences to be acquired by Amneal Pharmaceuticals
Transaction to create integrated global biosimilars platform combining development, manufacturing and commercial capabilities
PAGE partners with 8chili to launch AI and VR training platform for pharma manufacturing in India
Platform to support workforce development for quality, production and regulatory roles
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover…
Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility
Inspection cycle closed following February 2026 USFDA audit
Off label drug use and physician liability
Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University Mumbai, examines the complex legal and ethical…
Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States
USFDA approves ANDA for bioequivalent version of Xigduo XR
Zyax Chem acquires 26% stake in Gaymed Labs
Investment brings board representation and expansion plans in ophthalmic segment
OneSource and Orbicular secure USFDA tentative approval for generic semaglutide injection
Partnership progresses ANDA filing for generic version of Ozempic with manufacturing support from OneSource
India’s biopharma moment—If we get the ecosystem right
Krishna Sarma highlights the ecosystem requirements for advancing biopharma innovation in India
Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483
Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing engagements
Clinical exclusivity for indigenous medicines can improve long-term affordability and access
Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clinical data exclusivity, competitors may obtain…
Rusan Pharma secures PMDA GMP approval for Ankleshwar and Dehradun facilities
Approval from Japan regulator covers API and finished dosage manufacturing units
Lupin subsidiary enters settlement agreement with Humana in US antitrust litigation
Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admission of liability
Aurobindo Pharma secures USFDA approval for Glycerol Phenylbutyrate Oral Liquid
Company to launch product for urea cycle disorders with market size of US$ 50.2 million
Alembic Pharma gets USFDA nod for Methotrexate Injection USP, 50 mg/2 mL multi-dose vials and 1g/40…
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neoplastic diseases
Pharma firms accelerate regional capacity building to secure GLP-1 supply and mitigate geopolitical…
The shift reflects intensifying demand for metabolic therapies and growing logistics risk, signaling a structural move toward…
Rubicon Research acquires 85% stake in Arinna Lifesciences
Transaction valued at INR 200 crore to expand presence in CNS therapies and domestic formulations market
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
New pricing for weight management drug effective from April 3, 2026
Aurigene and Alveus Therapeutics advance collaboration with ALV-200 candidate nomination
Partnership supports drug discovery programmes for obesity and metabolic disease